Apr 30, 2026 07:06AM
Apr 30, 2026 06:59AM
Apr 20, 2026 08:00AM
Mar 27, 2026 03:39AM
Feb 27, 2026 06:55AM
Feb 26, 2026 07:36AM
Feb 26, 2026 07:00AM Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Feb 17, 2026 08:00AM
Jan 7, 2026 04:01PM
Oct 30, 2025 12:03PM
Oct 30, 2025 07:17AM
Oct 30, 2025 07:00AM
Oct 20, 2025 08:00AM
Aug 7, 2025 07:00AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 12c
Aug 7, 2025 06:59AM
Jul 28, 2025 08:00AM
Jun 6, 2025 01:46PM
May 1, 2025 07:06AM
May 1, 2025 07:00AM
Apr 23, 2025 08:00AM
Mar 6, 2025 04:24PM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 42c
Mar 6, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 15, 2025 10:00PM
Nov 7, 2024 08:08AM
Nov 7, 2024 08:00AM
Oct 28, 2024 08:00AM
Aug 8, 2024 04:17PM Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs
Aug 8, 2024 08:05AM
Aug 8, 2024 08:00AM
Jul 29, 2024 07:59AM
May 9, 2024 08:08AM
May 9, 2024 08:00AM
Apr 29, 2024 08:00AM
Mar 7, 2024 09:25AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 27c
Mar 7, 2024 08:00AM
Feb 29, 2024 08:00AM
Nov 9, 2023 09:12AM
Nov 9, 2023 08:00AM
Aug 10, 2023 08:01AM
Jun 19, 2023 09:00PM
Jun 4, 2023 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm
May 26, 2023 09:00PM
May 10, 2023 08:00AM
Mar 9, 2023 09:51PM
Feb 28, 2023 08:00AM
Feb 28, 2023 08:00AM
Feb 14, 2023 08:40PM
Feb 9, 2023 03:32PM TOP RANKED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
Feb 3, 2023 09:00PM

1,197,523 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All